(Q33159950)

23 July 2017

title

Healthcare and guidelines: a population-based survey of recorded medical problems and health surveillance for people with Down syndrome (English)

1 reference

23 July 2017

1 reference

Tuomo Määttä

1

1 reference

23 July 2017

Joonas Määttä

2

1 reference

23 July 2017

Tuula Tervo-Määttä

3

1 reference

23 July 2017

Anja Taanila

4

1 reference

23 July 2017

Markus Kaski

5

1 reference

23 July 2017

Matti Iivanainen

6

1 reference

23 July 2017

language of work or name

1 reference

19 April 2011

1 reference

Journal of Intellectual & Developmental Disability

23 July 2017

published in

1 reference

23 July 2017

volume

36

1 reference

23 July 2017

issue

2

1 reference

23 July 2017

page(s)

118-126

1 reference

American Academy of Pediatrics: Health supervision for children with Down syndrome

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

The four ages of Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Early onset of presbyacusis in Down syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Increase in incidence of medically treated thyroid disease in children with Down Syndrome after rerelease of American Academy of Pediatrics Health Supervision guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Improving the health of people with intellectual disabilities: outcomes of a health screening programme after 1 year

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Dementia and mortality in persons with Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Ophthalmic abnormalities in children with Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Psychiatric and behavioral disorders in persons with Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Obstacles in large-scale epidemiological assessment of sensory impairments in a Dutch population with intellectual disabilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Low adherence to national guidelines for thyroid screening in Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Longitudinal study of thyroid function in Down's syndrome in the first two decades

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Mortality and morbidity among older adults with intellectual disability: health services considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Medical conditions and medication use in adults with Down syndrome: a descriptive analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Effects of a comprehensive health assessment programme for Australian adults with intellectual disability: a cluster randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Health co-morbidities in ageing persons with Down syndrome and Alzheimer's dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Prevalence of hearing loss in 1598 adults with an intellectual disability: cross-sectional population based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Celiac disease in children and adolescents with Down syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Natural history of thyroid function in adults with Down syndrome--10-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease--pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Cost estimation of a health-check intervention for adults with intellectual disabilities in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Health of children 3 to 17 years of age with Down syndrome in the 1997-2005 national health interview survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

The prevalence of coeliac disease in Down's syndrome in Malta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Maladaptive behaviors related to dementia status in adults with Down syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Comorbidity, hospitalization, and medication use and their influence on mental and motor development of young infants with Down syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Trisomy 21 causes persistent congenital hypothyroidism presumably of thyroidal origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Prevalence, neonatal characteristics, and first-year mortality of Down syndrome: a national study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Medical issues among children and teenagers with Down syndrome in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

Alzheimer's disease in Down syndrome: neurobiology and risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13668250.2011.570253

10.1080/13668250.2011.570253

21 January 2018

Identifiers

DOI

1 reference

23 July 2017

1 reference